Abstracts - faqs.org

Abstracts

Health

Search abstracts:
Abstracts » Health

Gene therapy finds welcoming environment in China

Article Abstract:

China became the first country to have approved two drugs based on gene therapy with its State Food and Drug Administration in October 2003 approving Gendicine to treat head and neck cancers. The drug uses an adenovirus to deliver the tumor suppressor gene p53 into tumor cells and in November 2005, the agency approved Shanghai Sunway Biotech's H101, also an adenovirus, which targets cancer cells that lack p53.

Author: Jia, Hepeng
Publisher: Nature America, Inc.
Publication Name: Nature Medicine
Subject: Health
ISSN: 1078-8956
Year: 2006
China, Product development, Government regulation, Pharmaceutical preparations, Care and treatment, Pharmaceutical industry, Licensing, certification and accreditation, Cancer, Adenoviruses, Gendicine (Medication)

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Therapy on trial

Article Abstract:

The U.S. Food and Drug Administration (FDA) has suspended the gene therapy trial following the death of a participant in an experimental gene therapy clinical trial. The Recombinant DNA Advisory Committee (RAC) is planning to review the death of the Jolee Mohr at the University of Chicago Medical Center.

Author: Hughes, Virginia
Publisher: Nature America, Inc.
Publication Name: Nature Medicine
Subject: Health
ISSN: 1078-8956
Year: 2007
United States, Health aspects, United States. Food and Drug Administration

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Attenuation of seizures and neuronal death by adeno-associated virus vector galanin expression and secretion

Article Abstract:

The neuropeptide galanin can modulate seizure activity in vivo super 5,6, and the laminar protein fibronectin is usually secreted through a constitutive pathway. Neuroactive peptide expression and local secretion provides a new gene therapy platform for the treatment of neurological disorders.

Author: Haberman, Rebecca P., Samulski, Jude R., McCown, Thomas J.
Publisher: Nature America, Inc.
Publication Name: Nature Medicine
Subject: Health
ISSN: 1078-8956
Year: 2003
Neuropeptides, Nervous system diseases

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: Research, Gene therapy
Similar abstracts:
  • Abstracts: Intravenous therapy at home. The value of nursing
  • Abstracts: The status of local smoking regulations in North Carolina following a state preemption bill. Involuntary smoking in the restaurant workplace: a review of employee exposure and health effects
  • Abstracts: T cells bite the hand that feeds them. Embedding T cells in the matrix. Fatal attraction: Tumors beckon regulatory T cells
  • Abstracts: Local gene knockdown in the brain using viral-mediated RNA interference. Seizing hold of seizures
  • Abstracts: Enhanced insulin sensitivity, energy expenditure and thermogenesis in adipose-specific Pten suppression in mice
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.